Macrophages, Chronic Inflammation, and Insulin Resistance

被引:114
|
作者
Li, He [1 ]
Meng, Ya [1 ]
He, Shuwang [2 ]
Tan, Xiaochuan [1 ]
Zhang, Yujia [1 ]
Zhang, Xiuli [1 ]
Wang, Lulu [3 ,4 ]
Zheng, Wensheng [1 ,4 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Inst Mat Med, Beijing City Key Lab Drug Delivery Technol & Nove, Beijing 100050, Peoples R China
[2] Shandong DYNE Marine Biopharmaceut Co Ltd, Rongcheng 264300, Peoples R China
[3] Chinese Acad Med Sci & Peking Union Med Coll, Inst Med Biotechnol, Beijing 100050, Peoples R China
[4] 1 Xian Nong Tan St, Beijing 100050, Peoples R China
关键词
obesity; macrophages; chronic inflammation; insulin resistance; molecular mechanism; TUMOR-NECROSIS-FACTOR; ALTERNATIVELY ACTIVATED MACROPHAGES; ADIPOSE-TISSUE INFLAMMATION; DIET-INDUCED OBESITY; N-TERMINAL KINASE; SKELETAL-MUSCLE INFLAMMATION; LOW-GRADE INFLAMMATION; TNF-ALPHA ANTIBODY; PPAR-GAMMA; IMMUNE CELLS;
D O I
10.3390/cells11193001
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The prevalence of obesity has reached alarming levels, which is considered a major risk factor for several metabolic diseases, including type 2 diabetes (T2D), non-alcoholic fatty liver, atherosclerosis, and ischemic cardiovascular disease. Obesity-induced chronic, low-grade inflammation may lead to insulin resistance, and it is well-recognized that macrophages play a major role in such inflammation. In the current review, the molecular mechanisms underlying macrophages, low-grade tissue inflammation, insulin resistance, and T2D are described. Also, the role of macrophages in obesity-induced insulin resistance is presented, and therapeutic drugs and recent advances targeting macrophages for the treatment of T2D are introduced.
引用
收藏
页数:24
相关论文
共 50 条
  • [1] Macrophages, Inflammation, and Insulin Resistance
    Olefsky, Jerrold M.
    Glass, Christopher K.
    ANNUAL REVIEW OF PHYSIOLOGY, 2010, 72 : 219 - 246
  • [2] Insulin resistance and chronic inflammation
    Matulewicz, Natalia
    Karczewska-Kupczewska, Monika
    POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ, 2016, 70 : 1245 - 1257
  • [3] Macrophages, inflammation, adipose tissue, obesity and insulin resistance
    Bastarrachea, Raul A.
    Lopez-Alvarengaa, Juan Carlos
    Bolado-Garcia, Victoria Eugenia
    Tellez-Mendoza, Jorge
    Laviada-Molina, Hugo
    Comuzzie, Anthony G.
    GACETA MEDICA DE MEXICO, 2007, 143 (06): : 505 - 512
  • [4] Insulin resistance and inflammation in chronic kidney diseases
    Guebre-Egziabher, Fitsum
    Kalbacher, Emilie
    Fouque, Denis
    NEPHROLOGIE & THERAPEUTIQUE, 2009, 5 : S346 - S352
  • [5] Prehypertensioni Insulin Resistance, and Chronic Inflammation: The Insulin Resistance Atherosclerosis Study (IRAS)
    Haffner, Steven M.
    Lorenzo, Carlos
    DIABETES, 2009, 58 : A270 - A270
  • [6] Inflammation and insulin resistance: chronic renal disease features
    Guebre-Egziabher, Fitsum
    Juillard, Laurent
    Kalbacher, Emilie
    Bachetta, Justine
    Fouque, Denis
    NEPHROLOGIE & THERAPEUTIQUE, 2010, 6 : S7 - S12
  • [7] Colonic Macrophages "Remote Control'' Adipose Tissue Inflammation and Insulin Resistance
    Biswas, Subhra K.
    Bonecchi, Raffaella
    CELL METABOLISM, 2016, 24 (02) : 196 - 198
  • [8] Chronic subclinical inflammation as part of the insulin resistance syndrome -: The Insulin Resistance Atherosclerosis Study (IRAS)
    Festa, A
    D'Agostino, R
    Howard, G
    Mykkänen, L
    Tracy, RP
    Haffner, SM
    CIRCULATION, 2000, 102 (01) : 42 - 47
  • [9] Inflammation and Insulin Resistance in Diabetic Chronic Coronary Syndrome Patients
    Li, Tianyu
    Wang, Peizhi
    Wang, Xiaozeng
    Liu, Zhenyu
    Zhang, Zheng
    Zhang, Yongzhen
    Wang, Zhifang
    Feng, Yingqing
    Wang, Qingsheng
    Guo, Xiaogang
    Tang, Xiaofang
    Xu, Jingjing
    Song, Ying
    Chen, Yan
    Xu, Na
    Yao, Yi
    Liu, Ru
    Zhu, Pei
    Han, Yaling
    Yuan, Jinqing
    NUTRIENTS, 2023, 15 (12)
  • [10] Adipose tissue macrophages, low grade inflammation and insulin resistance in human obesity
    Heilbronn, Leonie K.
    Campbell, Lesley V.
    CURRENT PHARMACEUTICAL DESIGN, 2008, 14 (12) : 1225 - 1230